Brief: Vitrafy Life Sciences Announces Leadership Transition
05/08/2025 02:20
Aug 5 (Reuters) - Vitrafy Life Sciences Ltd VFY.AX: LEADERSHIP TRANSITION AT VITRAFY KATE MUNNINGS WILL RETIRE AS MANAGING DIRECTOR & CEO KATE MUNNINGS TO REMAIN AS NON-EXECUTIVE DIRECTOR BRENT OWENS APPOINTED AS MANAGING DIRECTOR & CEO Further company coverage: VFY.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vitrafy Life Sciences
See all newsAustralia's Vitrafy Life Sciences slumps on discounted placement
Brief: Vitrafy Life Sciences Receives Firm Commitments For A$30 Million Placement
Brief: Vitrafy Life Sciences Seeks Trading Halt
Brief: Vitrafy Life Sciences Enters Partnership With Vitalant Innovation Center
Brief: Vitrafy Life Sciences Posts HY Loss After Tax A$7.1 Million